ANEW Medical Partners With Okinawa Research Center to Develop Longevity Drugs
ANEW Medical (WENA) said Thursday it has partnered with researchers at Japan's Okinawa Research Center for Longevity Science for the development of its Klotho gene therapy in reducing age-related diseases.
Okinawa is among a set of global "Blue Zones" with high numbers of people who live to high ages and remain in good health.
ANEW said preliminary data suggests that the alpha-Klotho version of the human Klotho gene and its secreted alpha-Klotho protein isoform may contribute to long lifespans and protection against diseases such as Alzheimer's Disease. The company is developing a portfolio of therapies targeting the gene.
Price: 3.4200, Change: -0.20, Percent Change: -5.52